| ²é¿´: 1313 | »Ø¸´: 4 | ||
andana½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÌØÁ¢·ú°·µÄCASºÅ ÒÑÓÐ1È˲ÎÓë
|
| ÇëÎʸ÷λCASºÅ108605-62-5ºÍCASºÅ16345-81-8µ½µ×ÄĸöÊÇÌØÁ¢·ú°·µÄCASºÅ°¡£¿ÕâÁ½¸ö½á¹¹Ê½ÓÐÊ²Ã´Çø±ðÄØ£¿ |
» ²ÂÄãϲ»¶
¿¼Ñе÷¼Á£º¹ú¼Òµ°°×ÖÊ¿ÆÑ§ÖÐÐÄ£¨¹ú¼ÒÖØµãʵÑéÊÒ£©ºÍ°²»ÕÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÁªÅà
ÒѾÓÐ4È˻ظ´
»ªÄÏÀí¹¤´óѧ »ù´¡Ò½Ñ§Ñ§Ë¶ºÍÁÙ´²Ò½Ñ§Ñ§Ë¶µ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ63È˻ظ´
±±¾©ÐºÍҽѧԺ½ÜÇà¿ÎÌâ×éÕÐÆ¸¿ÆÑÐÖúÀí
ÒѾÓÐ0È˻ظ´
±±¾©ÐºÍҽѧԺ½ÜÇà¿ÎÌâ×éÕÐÆ¸¿ÆÑÐÖúÀí
ÒѾÓÐ0È˻ظ´
ÇóÖúÖйúÒ©µä1995Äê°æ¡¢¶þ²¿
ÒѾÓÐ0È˻ظ´
±±¾©ÐºÍҽѧԺ½ÜÇà¿ÎÌâ×éÕÐÆ¸¿ÆÑÐÖúÀí
ÒѾÓÐ0È˻ظ´
ʹÓÃMolAICalÉú³ÉС·Ö×ÓCHARMMÁ¦³¡ÍØÆËºÍ²ÎÊýÎļþ
ÒѾÓÐ0È˻ظ´
ÇóÖúhttps://www.pnas.org/doi/10.1073/pnas.2535777123 È«ÎÄ
ÒѾÓÐ0È˻ظ´
Õâ¸ö×Ô·¢¼ÓÑõ·´Ó¦µÄ»úÀíÊÇʲô£¿
ÒѾÓÐ7È˻ظ´
mouse103
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- DRDEPI: 16
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 0.384
- ½ð±Ò: 1423.7
- É¢½ð: 2586
- ºì»¨: 171
- ɳ·¢: 1
- Ìû×Ó: 1626
- ÔÚÏß: 411.4Сʱ
- ³æºÅ: 466716
- ×¢²á: 2007-11-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø
2Â¥2017-03-03 13:32:43
mouse103
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- DRDEPI: 16
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 0.384
- ½ð±Ò: 1423.7
- É¢½ð: 2586
- ºì»¨: 171
- ɳ·¢: 1
- Ìû×Ó: 1626
- ÔÚÏß: 411.4Сʱ
- ³æºÅ: 466716
- ×¢²á: 2007-11-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø
|
Title: Teriflunomide CAS Registry Number: 163451-81-8; 108605-62-5 (unspecified stereo) CAS Name: (2Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide Manufacturers' Codes: A-771726 Molecular Formula: C12H9F3N2O2 Molecular Weight: 270.21 Percent Composition: C 53.34%, H 3.36%, F 21.09%, N 10.37%, O 11.84% Literature References: Disease modifying antirheumatic drug (DMARD); active metabolite of leflunomide, q.v. Prepn: R. R. Bartlett, F.-J. Kämmerer, WO 9117748; eidem, US 5494911 (1991, 1996 both to Hoechst). Identification as active metabolite: J. W. Patterson et al., J. Med. Chem. 35, 507 (1992). Phamacokinetics: J. Lucien et al., Ther. Drug Monit. 17, 454 (1995). Inhibits dihydroorotate dehydrogenase: J. P. Davis et al., Biochemistry 35, 1270 (1996). Configurational study: G. Bertolini et al., J. Med. Chem. 40, 2011 (1997); and crystal structure: C. Papageorgiou et al., Bioorg. Chem. 25, 233 (1997). HPLC determn in plasma: V. Chan et al., J. Chromatogr. B 803, 331 (2004). Therap-Cat: Immunomodulator; in treatment of multiple sclerosis. Keywords: Immunomodulator. |
3Â¥2017-03-03 13:33:27
andana
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1511
- É¢½ð: 38
- ºì»¨: 1
- Ìû×Ó: 97
- ÔÚÏß: 185.3Сʱ
- ³æºÅ: 1027074
- ×¢²á: 2010-05-24
- רҵ: É«Æ×·ÖÎö
4Â¥2017-03-03 13:45:01
mouse103
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- DRDEPI: 16
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 0.384
- ½ð±Ò: 1423.7
- É¢½ð: 2586
- ºì»¨: 171
- ɳ·¢: 1
- Ìû×Ó: 1626
- ÔÚÏß: 411.4Сʱ
- ³æºÅ: 466716
- ×¢²á: 2007-11-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø
5Â¥2017-03-03 15:32:22









»Ø¸´´ËÂ¥
30
ͶƱ: